nach oben

Erschienen in:

01.06.2018 | Clinical study

Association between abiraterone and rhabdomyolysis

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

There seems to be an association between treatment with abiraterone and the development of rhabdomyolysis, according to study results reported in the Annals of Pharmacotherapy, and "health care practitioners caring for patients with prostate cancer receiving abiraterone therapy should be aware of this potentially serious adverse drug event". …

Moore DC, et al. Rhabdomyolysis With Abiraterone Exposure: A Brief Review of the Food and Drug Administration Adverse Event Reporting System (FAERS). Annals of Pharmacotherapy : Jun 2018. Available from: URL: http://doi.org/10.1177/1060028018783519

Titel: Association between abiraterone and rhabdomyolysis
Publikationsdatum: 01.06.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-48097-9

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Association between abiraterone and rhabdomyolysis

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Dabigatran etexilate overdose

Methotrexate

Pazopanib

Calcium/paricalcitol/warfarin

Gimeracil/oteracil/tegafur

Levamisole